Environment-sensitive and enzyme-sensitive MR contrast agents

Handbook of Experimental Pharmacology

Volumn 185, Issue PART2, 2008, Pages 37-57

  Querol, Manuel ^a   Bogdanov Jr , Alexei ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; CHELATING AGENT; CONTRAST MEDIUM; DIAGNOSTIC AGENT; ENZYME; FERRIC ION; FERRIC OXIDE; GADOLINIUM; METAL NANOPARTICLE; WATER;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; ELECTRON SPIN RESONANCE; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; REVIEW;

ANIMALS; CATIONS; CHELATING AGENTS; CONTRAST MEDIA; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENZYMES; FERRIC COMPOUNDS; GADOLINIUM; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; WATER;

EID: 52049110085     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-77496-9_3     Document Type: Article

References (70)

1. Aime S, Ascenzi P et al (1995) Molecular recognition of R-and T-states of human adult hemoglobin by a paramagnetic Gd (III) complex by means of the measurement of solvent water proton relaxation rate. J Am Chem Soc 117(36):9365-9366
2. Aime S, Botta M et al (1991) Inclusion complexes between b-cyclodextrin and b-benzyloxy-apropionic derivatives of paramagnetic DOTA-and DTPA-gadolinium (III) complexes. Magn Reson Chem 29(9): 923-927
3. Aime S, Botta M et al (1993) Paramagnetic gadolinium (III)-iron (III) heterobimetallic complexes of DTPA-bis-salicylamide. Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy 49A(9):1315-1322
4. Aime S, Botta M et al (1996) A new ytterbium chelate as contrast agent in chemical shift imaging and temperature sensitive probe for MR spectroscopy. Magn Reson Med 35(5):648-651
5. Aime S, Botta M et al (1997) Synthesis and NMR studies of three pyridine-containing triaza macrocyclic triacetate ligands and their complexes with lanthanide ions. Inorg Chem 36(14): 2992-3000
6. Aime S, Botta M et al (1999a) 1H and 17O-NMR relaxometric investigations of paramagnetic contrast agents for MRI. Clues for higher relaxivities. Coord Chem Rev 185-186:321-333
7. Aime S, Botta M et al (1999b) Prototropic and water-exchange processes in aqueous solutions of Gd (III) chelates. Accounts Chem Res 32(11):941-949
8. Aime S, Botta M et al (1999c) Contrast agents for magnetic resonance imaging: a novel route to enhanced relaxivities based on the interaction of a GdIII chelate with poly-b-cyclodextrins. Chem Eur J 5(4):1253-1260
9. Aime S, Botta M et al (1999d) Novel paramagnetic macromolecular complexes derived from the linkage of a macrocyclic Gd (III) complex to polyamino acids through a squaric acid moiety. Bioconj Chem 10(2):192-199
10. Aime S, Botta M et al (2000a) [GdPCP2A(H(2)O)(2)](-): a paramagnetic contrast agent designed for improved applications in magnetic resonance imaging. J Med Chem 43(21):4017-4024
11. Aime S, Botta M et al (2000b) A p(O2)-responsive MRI contrast agent based on the redox switch of manganese (II/III)-porphyrin complexes. Ang Chem, Intl Ed 39(4):747-750
12. Aime S, Cabella C et al (2002) Insights into the use of paramagnetic Gd (III) complexes in MRmolecular imaging investigations. J Magn Res Imag 16(4):394-406
13. Aime S, Cavallotti C et al (2004) Mannich reaction as a new route to pyridine-based polyaminocarboxylic ligands. Org Lett 6(8):1201-1204
14. Aime S, Fasano M et al (1998) Lanthanide (III) chelates for NMR biomedical applications. Chem Soc Rev 27(1):19-29
15. Andre JP, Toth E et al (1999) High relaxivity for monomeric Gd(DOTA)-based MRI contrast agents, thanks to micellar self organization. Chem Eur J 5(10):2977-2983
16. Artemov D, Bhujwalla ZM et al (2004) Magnetic resonance imaging of cell surface receptors using targeted contrast agents. Curr Pharm Biotechnol 5(6):485-494
17. Bogdanov A Jr, Matuszewski L et al (2002) Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol Imaging 1(1):16-23
18. Brennan ML, Penn MS et al (2003) Prognostic value of myeloperoxidase in patients with chest pain. New England J Med 349(17):1595-1604
19. Bruce JI, Dickins RS et al (2000) The selectivity of reversible oxy-anion binding in aqueous solution at a chiral europium and terbium center: signaling of carbonate chelation by changes in the form and circular polarization of luminescence emission. J Am Chem Soc 122(40): 9674-9684
20. Brucher E, Sherry AD (2001) Stability and toxicity of contrast agents. In: Merbach AE, Toth E (eds) The chemistry of contrast agents in medical magnetic resonance imaging. Wiley, Chichester, pp 243-281
21. Burai L, Toth E et al (2000) Solution and solid-state characterization of Eu (II) chelates: a possible route towards redox responsive MRI contrast agents. Chemistry 6(20):3761-3770
22. Burai L, Scopelliti R et al (2002) EuII-cryptate with optimal water exchange and electronic relaxation: a synthon for potential pO2 responsive macromolecular MRI contrast agents. Chem Commun (20): 2366-2367
23. Caravan P, Ellison JJ et al (1999) Gadolinium (III) Chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 99(9):2293-2352
24. Caravan P, Zhang Z et al (2001) Paradigms for increasing the relaxivity of MRI contrast agents. Abstracts of Papers, 222nd ACS National Meeting, Chicago, August 26-30, 2001, INOR-213
25. Caravan P (2003) Targeted molecular imaging with MRI. Abstracts of Papers, 226th ACS National Meeting, New York, September 7-11, 2003, INOR-541
26. Chen JW, Pham W et al (2004) Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis. Magn Reson Med 52(5):1021-1028
27. Clarke SE,Weinmann HJ et al (2000) Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits. Radiology 214(3):787-794
28. Comblin V, Gilsoul D et al (1999) Designing new MRI contrast agents: a coordination chemistry challenge. Coordination Chem Rev 185-186:451-470
29. Costa J, Ruloff R et al (2005) Rigid MIIL2Gd2III (M = Fe, Ru) complexes of a terpyridinebased heteroditopic chelate: a class of candidates for MRI contrast agents. J Am Chem Soc 127(14):5147-5157
30. Curtet C, Maton F et al (1998) Polylysine-Gd-DTPAn and polylysine-Gd-DOTAn coupled to anti-CEA F(ab')2 fragments as potential immunocontrast agents. Relaxometry, biodistribution, and magnetic resonance imaging in nude mice grafted with human colorectal carcinoma. Invest Radiol 33(10):752-761
31. Dong Q, Hurst DR et al (1998) Magnetic resonance angiography with gadomer-17. An animal study original investigation. Invest Radiol 33(9):699-708
32. Duimstra JA, Femia FJ et al (2005) A gadolinium chelate for detection of beta-glucuronidase: a self-immolative approach. J Am Chem Soc 127(37):12847-12855
33. Fossheim SL, Fahlvik AK et al (1998) Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity. Mag Reson Imag 17(1): 83-89
34. Fossheim SL, Il'yasov KA et al. (2000) Thermosensitive paramagnetic liposomes for temperature control during MR imaging-guided hyperthermia: in vitro feasibility studies. Acad Radiol 7(12):1107-1115
35. Frias JC, Williams KJ et al (2004) Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc 126(50):16316-16317
36. Gries H, Rosember D et al (1982). Paramagnetische Komplexsalze deren Herstellung and Verwendung bei der NMR-Diagnostik.EP 0 071 564 A1
37. Grynkiewicz G, Poenie M et al (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260(6):3440-3450
38. Hall J, Haener R et al (1998) Relaxometric and luminescence behavior of triaquahexaazamacrocyclic complexes, the gadolinium complex displaying a high relaxivity with a pronounced pH dependence. New J Chem 22(6):627-631
39. Hanaoka K, Kikuchi K et al (2002) Design and synthesis of a novel magnetic resonance imaging contrast agent for selective sensing of zinc ion. Chem Biol 9(9):1027-1032
40. Hovland R, Glogard C et al (2001) Gadolinium DO3A derivatives mimicking phospholipids; preparation and in vitro evaluation as pH responsive MRI contrast agents. J Chem Soc, Perkin Trans 2 (6):929-933
41. Kornguth S, Anderson M et al (1990) Glioblastoma multiforme: MR imaging at 1.5 and 9.4 T after injection of polylysine-DTPA-Gd in rats. AJNR Am J Neuroradiol 11(2):313-318
42. Lauffer RB (1987) Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 87(5):901-927
43. Lauffer RB (1990a) Magnetic resonance contrast media: principles and progress. Magn Reson Q 6(2):65-84
44. Lauffer RB (1990b) Mechanisms of magnetic resonance contrast enhancement by relaxivity and magnetic susceptibility agents. Invest Radiol 25 Suppl 1:S32-S33
45. Lauffer RB (1991) Targeted relaxation enhancement agents for MRI. Magn Reson Med 22(2): 339-342
46. Lauffer RB, McMurry TJ et al (1997). Bioactivated diagnostic imaging contrast agents. Application: WO, (Epix Medical, USA)
47. Li W-h, Fraser SE et al (1999) A calcium-sensitive magnetic resonance imaging contrast agent. J Am Chem Soc 121(6):1413-1414
48. Li W-h, Parigi G et al (2002) Mechanistic studies of a calcium-dependent MRI contrast agent. Inorg Chem 41(15):4018-4024
49. Livramento JB, Toth E et al (2005) High relaxivity confined to a small molecular space: a metallostar-based, potential MRI contrast agent. Angew Chem Int Ed Engl 44(10):1480-1484
50. Lokling KE, Fossheim SL et al (2001) pH-sensitive paramagnetic liposomes as MRI contrast agents: in vitro feasibility studies. Mag Reson Imag 19(5):731-738
51. Louie AY, Huber MM et al. (2000) In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotech 18(3):321-325
52. Louie AY, Meade TJ (2000) Recent advances in MRI: novel contrast agents shed light on in vivo biochemistry. Trends Biochem Sci, pp 7-11
53. Lowe MP, Parker D et al (2001) pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. J Am Chem Soc 123(31):7601-7609
54. Marchal G, Bosmans H et al (1990) MR angiography with gadopentetate dimeglumine-polylysine: evaluation in rabbits. AJR Am J Roentgenol 155(2):407-411
55. Meade TJ, Taylor AK, Bull SR (2003) New magnetic resonance contrast agents as biochemical reporters. Curr Opin Neurobiol 13(5):597-602
56. Merbach AE, Toth E (2001) The chemistry of contrast agents in medical magnetic resonance imaging. Wiley, Chichester
57. Mikawa M, Miwa N et al (2000) Gd(3+)-loaded polyion complex for pH depiction with magnetic resonance imaging. J Biomed Mater Res 49(3):390-305
58. Moats RA, Fraser SE et al (1997) A smart magnetic resonance imaging agent that reports on specific enzymic activity. Angew Chem, Int Ed 36(7):726-728
59. Nivorozhkin A L, Kolodziej AF et al (2001) Enzyme-activated Gd3+ magnetic resonance imaging contrast agents with a prominent receptor-induced magnetization enhancement. Angew Chem, Int Ed 40(15):2903-2906
60. Parker D, Williams JAG (1996) Getting exited about lanthanide complexation chemistry. J Chem Soc, Dalton Transactions (18):3613-3628
61. Querol M, Chen JW et al (2005) DTPA-bisamide-based MR sensor agents for peroxidase imaging. Org Lett 7(9):1719-1722
62. Sipkins DA, Cheresh DA et al (1998) Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 4(5):623-626
63. Toth E, Helm L et al (2002) Relaxivity of MRI contrast agents. Top Curr Chem 221:61-101
64. Toth E, Bolskar RD et al (2005) Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents. J Am Chem Soc 127(2):799-805
65. Van Hecke P, Marchal G et al. (1991) NMR imaging study of the pharmacodynamics of polylysinegadolinium-DTPA in the rabbit and the rat. Magn Reson Imaging 9(3):313-321
66. Wang SC, Wikstrom MG et al (1990) Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. Radiology 175(2):483-488
67. Woods M, Zhang S et al (2003) pH-sensitive modulation of the second hydration sphere in lanthanide (III) tetraamide-DOTA complexes: a novel approach to smartMRcontrast media. Chem Eur J 9(19):4634-4640
68. Woods M, Kiefer GE et al (2004) Synthesis, relaxometric and photophysical properties of a new pH-responsive MRI contrast agent: the effect of other ligating groups on dissociation of a p-nitrophenolic pendant arm. J Am Chem Soc 126(30):9248-9256
69. Zhang S, Wu K et al (1999) A novel pH-sensitive MRI contrast agent. Angew Chem, Int Ed 38(21):3192-3194
70. Zhang S, Merritt M et al (2003) PARACEST agents: modulating MRI contrast via water proton exchange. Accounts of Chem Res 36(10):783-790